While there is general consensus that screening adults over age 50 for colorectal cancer (the second leading cause of death from cancer in the US) is a valuable preventive intervention, there is some uncertainty about screening strategies, partly because of the number of available technologies and other factors affecting choice of strategy and partly because of a lack of knowledge about the natural history of the disease. These uncertainties have led to similar confusion about the proper cost-effective analysis (CEA) models screening modules. This publication results from a workshop convened by the Institute of Medicine's National Cancer Policy Board in which five different research teams compared their chosen (CEA) models--the Harvard, Ladabaum, Miscan, Vanderbilt, and Vijan models--with the intention being to provide insights into the different structures and assumptions of the models and differences in analysis resulting from the models. The workshop also explored the current state of knowledge on the key inputs for the models and identified areas of further research. Annotation ©2006 Book News, Inc., Portland, OR (booknews.com)
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Michael Pignone, Louise Russell and Judith Wagner, Editors, Institute of Medicine and National Research Council
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: PAPER CAVALIER UK, London, Vereinigtes Königreich
Zustand: good. A good reading copy. May contain markings or be a withdrawn library copy. Bestandsnummer des Verkäufers 9780309095396-4
Anzahl: 1 verfügbar